News

On World AIDS Day 2025, Fluorobiotech joins the global community in remembering the lives lost to HIV/AIDS, honoring the resilience of those living with…

Fluorobiotech is proud to announce that we have officially been awarded ISO 13485 certification, a major achievement in our ongoing mission to enable…

This week, Fluorobiotech’s COO, Ross Rayne Vermeulen, attended a landmark event in Johannesburg celebrating the launch of clinical trials for South Africa’s…

Last week, Fluorobiotech representatives Ross Rayne Vermeulen and Marthinus Janse van Vuuren attended the Africa Tech Festival, one of the continent’s…

Last week, Fluorobiotech had the pleasure of welcoming representatives from the Medicines Patent Pool (MPP), Dr. Monica Moschioni (PhD, MPH) and Umut…

A landmark study presented at the 2025 European Society for Medical Oncology (ESMO) Congress by The University of Texas MD Anderson Cancer Center has…

Fluorobiotech is proud to share that the company and its co-founders, Dr. Du Preez van Staden and Dr. Ross Rayne Vermeulen, were recently profiled by the…

Fluorobiotech is proud to congratulate our Chief Quality Officer, Etienne du Toit, on the successful completion of the CQI and IRCA Certified Medical…

Fluorobiotech proudly joins the national celebration of National Science Week in South Africa – a time to reflect on the transformative role of science and…

Fluorobiotech CEO, Dr. Du Preez van Staden, was recently invited to speak at the AUDA-NEPAD Home Grown Solutions (HGS) Masterclass, a high-impact learning…